Industry / Jordan
Biologics: New Area For Investment
January 2010 | Industry Trend AnalysisTo read the full article, please choose one of the following options:
Subcribers please log in
According to the Jordanian Food and Drug Administration (JFDA), domestic drugmakers in the country are applying for permission to begin manufacturing biologics. As yet, no licences have been issued, meaning that all drug production in Jordan remains for pharmaceuticals only.

